Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is standard of care for muscle-invasive bladder cancer (MIBC). However, NAC is used in less than 20% of patients with MIBC. Our goal is to investigate factors that contribute to underutilization NAC to facili...
Main Authors: | Filipe LF. Carvalho, Alexander Zeymo, Jillian Egan, Colleen H. Kelly, Chaoyi Zheng, John H. Lynch, Jonathan Hwang, Lambros Stamatakis, Ross E. Krasnow, Keith J. Kowalczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2020-07-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-390.pdf |
Similar Items
-
ORTHOTOPIC INTESTINOPLASTY OF URINARY BLADDER - A COMPLEX APPROACH
by: I. V. Semenyakin, et al.
Published: (2012-07-01) -
Simple cyst of urinary bladder
by: Yang Bo
Published: (2014-01-01) -
Risk groups in bladder cancer patients treated with radical cystectomy
by: Eva Mallen, et al.
Published: (2015-02-01) -
Inflammatory myofibroblastic bladder tumor: A very rare presentation
by: Raphael Flavio Fachini Cipriani, et al.
Published: (2021-11-01) -
The Role of Chemotherapy and Radiotherapy in the Surgical Management of Muscle Invasive Bladder Cancer
by: Joshua Luck
Published: (2014-10-01)